Sichuan Kelun Pharmaceutical Co Ltd (002422) — Capital Reinvestment Ratio
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥537.31 Million) in capital expenditures (CN¥393.58 Million). See Sichuan Kelun Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Kelun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Sichuan Kelun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. For live market cap and broader valuation context, see 002422 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +64.4% |
| 2024 | 0.37x | CN¥4.49 Billion | CN¥1.68 Billion | ▲ +12.7% |
| 2023 | 0.33x | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +15.7% |
| 2022 | 0.29x | CN¥3.13 Billion | CN¥896.02 Million | ▼ -17.7% |
| 2021 | 0.35x | CN¥2.85 Billion | CN¥990.56 Million | ▼ -37.3% |
| 2020 | 0.55x | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -7.6% |
| 2019 | 0.60x | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +33.4% |
| 2018 | 0.45x | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -63.3% |
| 2017 | 1.23x | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +54.7% |
| 2016 | 0.79x | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -46.5% |
| 2015 | 1.48x | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -34.4% |
| 2014 | 2.26x | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥168.42 Million | CN¥175.05 Million | — |